Key Market Indicators
Estonian Diagnostic Reagent Sales are projected to soar, reaching approximately €25 million by 2028. This marks a significant increase from the €13 million recorded in 2023, translating to an impressive annual growth rate of 9.7%. In 2023, Estonia held the 13th spot in the global ranking, with Greece narrowly ahead at the same value of €13 million. Spain, the United Kingdom, and Finland claimed the second, third, and fourth positions, respectively. In terms of imports, Estonia's Diagnostic Reagent Import is expected to hit about $29 million by 2028, up from $26 million in 2023. This growth reflects a steady annual increase of 1.8% since 2000. On the export front, Estonia's Diagnostic Reagent Export is anticipated to rise to roughly $8.5 million by 2028, from $7.4 million in 2023. This represents an average annual growth rate of 2.3%, with the supply having increased by 3.5% per year since 2000. In the 2023 rankings, Estonia stood at 49th, with Cyprus slightly ahead at the same $7.4 million mark. Germany, the Netherlands, and the United Kingdom were the top three exporters, respectively.
